VIDEO: UC Davis Researchers Visualize Formation of a New Synapse
A protein called neuroligin that is implicated in some forms of autism is critical to the construction of a working synapse, locking neurons together like "molecular Velcro," a study lead by a team of UC Davis researchers has found.
New Data Demonstrate Potential for Early Detection of Alzheimer's Disease
Data published in June demonstrated that minimally-invasive biospectroscopy was able to identify changes in oxidative stress levels in blood plasma, which may prove to be a useful biomarker in the early detection of Alzheimer's disease.
Could Hormones Explain Gender Differences in Neurological Disease?
Recently published research suggests that a number of estrogens acting through their receptors affect the dopamine transporter, which may explain trends in timing of women's susceptibility to neurological diseases.
VIDEO:Controlling the Brain with Optogenics
Using flashes of light delivered via fiber optics threaded through the skull, they have made mice run in circles and flies flap their wings.
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
Connexon Creative Launches Mammary Cell News
Mammary Cell News is a weekly e-newsletter that keeps members of the mammary cell community informed by providing the latest news from all areas of the field, including its science, research and business.
CEO Pay of 2008: Who Makes What in Big Biotech?
Since biotech companies each have their own approach to reporting CEO pay, ranking were based on total compensation reported in these companies' SEC filings.
Senator Cardin Pledges to Fight for Biotech Funding
Some local life sciences players urged congressional leaders to significantly hike the amount of federal funding for small business research grants in testimony for a Senate committee hearing on whether the stimulus bill missed the boat with smaller biotechs.
Jerusalem to Begin Massive Investment in Biotech Companies
The City of Jerusalem plans to raise and invest 100 million shekels ($25 million) over the next five years in health and life science companies in a bid to create jobs and to gain a reputation for the metropolis as an international partner in the field.
Bob Klein to Leave CIRM Chairman Job
Bob Klein, the architect of California's $3 billion stem cell research funding program, will not seek a new term as chairman of the agency.
Despite Odds, Cities Race to Bet on Biotech
At a recent global biotech convention in Atlanta, 27 states, including Hawaii and Oklahoma, paid as much as $100,000 each to entice companies on the exhibition floor. All this for a highly risky industry that has turned a profit only one year in the past four decades.
Plan Would Regulate Michigan Stem Cell Research
The first test of how much control state lawmakers might try to exert over embryonic stem cell research in Michigan is surfacing at the Capitol.
